UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk

Carcinogenesis (New York), 1997-07, Vol.18 (7), p.1285-1289

1997

Volltextzugriff (PDF)

Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil

Annals of oncology, 2006-02, Vol.17 (2), p.252-258

2006

Volltextzugriff (PDF)

Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil

Annals of oncology, 2008-06, Vol.19 (6), p.1154-1159

2008

Volltextzugriff (PDF)

Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates

The Journal of biological chemistry, 1990-06, Vol.265 (18), p.10484-10491

1990

Volltextzugriff (PDF)

Arg-242 is necessary for allosteric coupling of cyclic AMP-binding sites A and B of RI subunit of cyclic AMP-dependent protein kinase

The Journal of biological chemistry, 1994-09, Vol.269 (37), p.23025-23031

1994

Volltextzugriff (PDF)

Selective Modulation of Protein Kinase Isozymes by the Site-Selective Analog 8-chloroadenosine 3′,5′-cyclic Monophosphate Provides a Biological Means for Control of Human Colon Cancer Cell Growth

Proceedings of the National Academy of Sciences - PNAS, 1988-09, Vol.85 (17), p.6319-6322

1988

Volltextzugriff (PDF)

Multicenter Phase II Study of Nordic Fluorouracil and Folinic Acid Bolus Schedule Combined With Oxaliplatin As First-Line Treatment of Metastatic Colorectal Cancer

Journal of clinical oncology, 2004-01, Vol.22 (1), p.31-38

2004

Volltextzugriff (PDF)

The expression of cAMP-dependent protein kinase subunits is differentially regulated during liver regeneration

The Journal of biological chemistry, 1989-03, Vol.264 (8), p.4374-4382

1989

Volltextzugriff (PDF)

Detection of Lymph Node Micrometastases in Colorectal Cancer

Scandinavian journal of gastroenterology, 2003-02, Vol.38 (2), p.125-132

2003

Volltextzugriff (PDF)

The rate of recombination of the subunits (RI and C) of cAMP-dependent protein kinase depends on whether one or two cAMP molecules are bound per RI monomer

The Journal of biological chemistry, 1990-11, Vol.265 (32), p.19507-19516

1990

Volltextzugriff (PDF)

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

Acta oncologica, 2007, Vol.46 (7), p.982-988

2007

Volltextzugriff (PDF)

Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder

Anticancer research, 1998-07, Vol.18 (4A), p.2675

1998

Volltextzugriff (PDF)

Evidence that cyclic nucleotides activating rabbit muscle protein kinase I interact with both types of cAMP binding sites associated with the enzyme

The Journal of biological chemistry, 1983-01, Vol.258 (2), p.1041-1049

1983

Volltextzugriff (PDF)

Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type

International journal of cancer, 1998-02, Vol.79 (1), p.91-95

1998

Volltextzugriff (PDF)

Mutations that alter the charge of type I regulatory subunit and modify activation properties of cyclic AMP-dependent protein kinase from S49 mouse lymphoma cells

The Journal of biological chemistry, 1991-02, Vol.266 (6), p.3547-3553

1991

Volltextzugriff (PDF)

Phase II study of short-time infusion of oxaliplatin in combination with capecitabine (XELOX 30 ) in patients with progressive colorectal cancer after irinotecan and 5-fluorouracil (FU) treatment

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3562-3562

2004

Volltextzugriff (PDF)

Phase II study of short-time infusion of oxaliplatin in combination with capecitabine (XELOX 30 ) in patients with progressive colorectal cancer after irinotecan and 5-fluorouracil (FU) treatment

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3562-3562

2004

Volltextzugriff (PDF)

The separate estimation of cAMP intracellularly bound to the regulatory subunits of protein kinase I and II in glucagon-stimulated rat hepatocytes

The Journal of biological chemistry, 1985-03, Vol.260 (6), p.3393-3401

1985

Volltextzugriff (PDF)

Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase

The Journal of biological chemistry, 1986-01, Vol.261 (3), p.1208-1214

1986

Volltextzugriff (PDF)

Characterization of the interchain and intrachain interactions between the binding sites of the free regulatory moiety of protein kinase I

The Journal of biological chemistry, 1984-02, Vol.259 (4), p.2291-2301

1984

Volltextzugriff (PDF)

Mutations that prevent cyclic nucleotide binding to binding sites A or B of type I cyclic AMP-dependent protein kinase

The Journal of biological chemistry, 1988-11, Vol.263 (33), p.17397-17404

1988

Volltextzugriff (PDF)

Isoleucine 368 is involved in low-affinity binding of N6-modified cAMP analogues to site B of the regulatory subunit of cAMP-dependent protein kinase I

Biochemical journal, 1996-05, Vol.316 ( Pt 1) (Pt 1), p.337-343

1996

Volltextzugriff (PDF)

The effect of ligands of phenylalanine 4-monooxygenase on the cAMP-dependent phosphorylation of the enzyme

The Journal of biological chemistry, 1984-09, Vol.259 (18), p.11242-11248

1984

Volltextzugriff (PDF)

Isoleucine 368 is involved in low-affinity binding of N super(6)-modified cAMP analogues to site B of the regulatory subunit of cAMP-dependent protein kinase I

Biochemical journal, 1996-01, Vol.316 (1), p.337-343

1996

Volltextzugriff (PDF)

Aldolase B A149P mutation and hereditary fructose intolerance are not associated with sudden infant death syndrome

Acta Paediatrica, 1995-08, Vol.84 (8), p.947-948

1995

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(82)
Tagungsberichte
(2)

Sprache

Englisch
(75)
Norwegisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(34)
Biological And Medical Sciences
(32)
Humans
(29)
Animals
(27)
Cyclic Amp - Metabolism
(26)
Male
(24)
Binding Sites
(22)
Protein Kinases - Metabolism
(21)
Biochemistry & Molecular Biology
(17)
Female
(17)
Medical Sciences
(17)
Aged
(15)
Fundamental And Applied Biological Sciences. Psychology
(15)
Middle Aged
(15)
Analytical, Structural And Metabolic Biochemistry
(13)
Cyclic Amp - Analogs & Derivatives
(13)
Enzymes And Enzyme Inhibitors
(13)
Transferases
(13)
Kinetics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk

Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil

Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil

Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates

Arg-242 is necessary for allosteric coupling of cyclic AMP-binding sites A and B of RI subunit of cyclic AMP-dependent protein kinase

Selective Modulation of Protein Kinase Isozymes by the Site-Selective Analog 8-chloroadenosine 3′,5′-cyclic Monophosphate Provides a Biological Means for Control of Human Colon Cancer Cell Growth

Multicenter Phase II Study of Nordic Fluorouracil and Folinic Acid Bolus Schedule Combined With Oxaliplatin As First-Line Treatment of Metastatic Colorectal Cancer

The expression of cAMP-dependent protein kinase subunits is differentially regulated during liver regeneration

Detection of Lymph Node Micrometastases in Colorectal Cancer

The rate of recombination of the subunits (RI and C) of cAMP-dependent protein kinase depends on whether one or two cAMP molecules are bound per RI monomer

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder

Evidence that cyclic nucleotides activating rabbit muscle protein kinase I interact with both types of cAMP binding sites associated with the enzyme

Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type

Mutations that alter the charge of type I regulatory subunit and modify activation properties of cyclic AMP-dependent protein kinase from S49 mouse lymphoma cells

Phase II study of short-time infusion of oxaliplatin in combination with capecitabine (XELOX 30 ) in patients with progressive colorectal cancer after irinotecan and 5-fluorouracil (FU) treatment

Phase II study of short-time infusion of oxaliplatin in combination with capecitabine (XELOX 30 ) in patients with progressive colorectal cancer after irinotecan and 5-fluorouracil (FU) treatment

The separate estimation of cAMP intracellularly bound to the regulatory subunits of protein kinase I and II in glucagon-stimulated rat hepatocytes

Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase

Characterization of the interchain and intrachain interactions between the binding sites of the free regulatory moiety of protein kinase I

Mutations that prevent cyclic nucleotide binding to binding sites A or B of type I cyclic AMP-dependent protein kinase

Isoleucine 368 is involved in low-affinity binding of N6-modified cAMP analogues to site B of the regulatory subunit of cAMP-dependent protein kinase I

The effect of ligands of phenylalanine 4-monooxygenase on the cAMP-dependent phosphorylation of the enzyme

Isoleucine 368 is involved in low-affinity binding of N super(6)-modified cAMP analogues to site B of the regulatory subunit of cAMP-dependent protein kinase I

Aldolase B A149P mutation and hereditary fructose intolerance are not associated with sudden infant death syndrome

Suchergebnisse filtern